Cargando…
Circulating Tumor DNA-Based Genomic Profiling Assays in Adult Solid Tumors for Precision Oncology: Recent Advancements and Future Challenges
SIMPLE SUMMARY: The use of liquid biopsy for tumor genomic profiling to identify genomic biomarkers for targeted therapies has revolutionized the clinical practice in oncology management. In this review, we have summarized the recent advancements of liquid biopsy-based genomic profiling that have le...
Autores principales: | Chan, Hiu Ting, Chin, Yoon Ming, Low, Siew-Kee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265547/ https://www.ncbi.nlm.nih.gov/pubmed/35805046 http://dx.doi.org/10.3390/cancers14133275 |
Ejemplares similares
-
Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients
por: Chan, Hiu Ting, et al.
Publicado: (2023) -
Rapid genomic profiling of circulating tumor DNA in non-small cell lung cancer using Oncomine Precision Assay with Genexus™ integrated sequencer
por: Low, Siew-Kee, et al.
Publicado: (2022) -
Ultradeep targeted sequencing of circulating tumor DNA in plasma of early and advanced breast cancer
por: Chin, Yoon Ming, et al.
Publicado: (2020) -
Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
por: Deveson, Ira W., et al.
Publicado: (2021) -
Circulating tumor cells: quintessential precision oncology presenting challenges for biology
por: Morris, Rebecca J.
Publicado: (2017)